OOIR: Observatory of International Research

Papers

(The H4-Index of Molecular Oncology is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Targeting immunogenic cell death in cancer	471
Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A	148
Clinical utility of circulating tumor cells: an update	120
Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS–mitochondrial fission–mitophagy axis	96
Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer	70
Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment	70
Global mapping of cancers: The Cancer Genome Atlas and beyond	68
iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation	60
LncRNA NKX2‐1‐AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR‐2 signaling pathway in gastric cancer	58
METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5	57
Cancer diagnostics based on plasma protein biomarkers: hard times but great expectations	57
Enhancing cancer‐associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis	55
Cellular senescence and the tumour microenvironment	54
Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7	52
Immune response drives outcomes in prostate cancer: implications for immunotherapy	51
FOXD1‐AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway	51
Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook	49
Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer	49
Tobacco control policies in the 21st century: achievements and open challenges	46
Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis	45
Fragment‐based drug discovery—the importance of high‐quality molecule libraries	44
Circulating platelets as liquid biopsy sources for cancer detection	41
Circulating exosomalmiR‐363‐5pinhibits lymph node metastasis by downregulatingPDGFBand serves as a potential noninvasive biomarker for breast cancer	40
Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2	39
Circulating tumor cell profiling for precision oncology	39

Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR‐140‐3p/SKA2 axis	39
TGFBI modulates tumour hypoxia and promotes breast cancer metastasis	38
A novel prognostic mRNA/miRNA signature for esophageal cancer and its immune landscape in cancer progression	38
Autophagy at the intersection of aging, senescence, and cancer	37
Lipidomic profiling of exosomes from colorectal cancer cells and patients reveals potential biomarkers	37
A novel cell‐free DNA methylation‐based model improves the early detection of colorectal cancer	36
Targeting senescence as an anticancer therapy	36
MYC and therapy resistance in cancer: risks and opportunities	36
Extracellular vesicles and oncogenic signaling	35
FOXM1D potentiates PKM2‐mediated tumor glycolysis and angiogenesis	35
Protein palmitoylation in cancer: molecular functions and therapeutic potential	35
Resistance to DNA repair inhibitors in cancer	35